Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western KenyaSTOUTE, José A; GOMBE, Joash; STEWART, V. Ann et al.Vaccine. 2007, Vol 25, Num 1, pp 176-184, issn 0264-410X, 9 p.Article

Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccinesLIVINGSTON, Brian D; NEWMAN, Mark; CRIMI, Claire et al.Vaccine. 2001, Vol 19, Num 32, pp 4652-4660, issn 0264-410XArticle

Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus InfectionsDEPLA, Erik; VAN DER AA, Annegret; BABE, Lilia et al.Journal of virology. 2008, Vol 82, Num 1, pp 435-450, issn 0022-538X, 16 p.Article

Absence of viral escape within a frequently recognized HLA-A26-restricted CD8⁺ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage siteNEUMANN-HAEFELIN, Christoph; KILLINGER, Thomas; TIMM, Jorg et al.Journal of general virology. 2007, Vol 88, pp 1986-1991, issn 0022-1317, 6 p., 7Article

Intrahepatic CD8⁺ T-cell failure during chronic hepatitis C virus infectionSPANGENBERG, Hans Christian; VIAZOV, Sergei; KERSTING, Nadine et al.Hepatology (Baltimore, Md.). 2005, Vol 42, Num 4, pp 828-837, issn 0270-9139, 10 p.Article

A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adultsXIA JIN; NEWMAN, Mark J; NOONAN, Elizabeth et al.Vaccine. 2009, Vol 27, Num 50, pp 7080-7086, issn 0264-410X, 7 p.Article

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malariaKESTER, Kent E; MCKINNEY, Denise A; PALENSKY, Jolie et al.The Journal of infectious diseases. 2001, Vol 183, Num 4, pp 640-647, issn 0022-1899Article

Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adultsKESTER, Kent E; HEPPNER, D. Gray; HOLLAND, Carolyn et al.Vaccine. 2014, Vol 32, Num 49, pp 6683-6691, issn 0264-410X, 9 p.Article

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adultsKESTER, Kent E; MCKINNEY, Denise A; KRZYCH, Urszula et al.Vaccine. 2007, Vol 25, Num 29, pp 5359-5366, issn 0264-410X, 8 p.Article